human M-SAA3 peptide (University of Nebraska Medical Center)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namehuman M-SAA3 peptide (University of Nebraska Medical Center)
Drug Alias Namehuman mammary-associated serum amyloid A3 peptide (UNMC)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionSerum amyloid A protein stimulants
TargetsSerum amyloid A protein
Therapy Area/IndicationsGastroenteritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Nebraska Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUNeMed CorpUniversity Of Nebraska Medical Center
Active IndicationsN/A
Inactive IndicationsGastroenteritis

Other Information

ATC CodeN/A
Related LinksN/A